HIV/AIDS late presentation and its associated factors in China from 2010 to 2020: a systematic review and meta-analysis

Abstract

Background Late presentation to HIV/AIDS care presents serious health concerns, like increased transmission and high healthcare costs, increased mortality, early development of opportunistic infection, increased risk of antiretroviral therapy drug resistance. Despite the effort to contain the HIV/AIDS epidemic, LP has remained an impediment to individual immune reconstitution and public health. Objective This review aimed to estimate the prevalence and determine the factors associated with late presentation to HIV/AIDS care. Methods We searched PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Wanfang, and Weipu database for articles published from 2010 to 2020. We utilized I2 statistics and Q-test to estimate heterogeneity between studies. Random-effects meta-analysis models were used to calculate the aggregate odds ratio of late presentation to HIV/AIDS care. Results Of 9563 titles and abstracts retrieved, 189 were identified as potentially eligible and 39 fulfilled the inclusion criteria. The pooled prevalence of late presentation to HIV/AIDS care was 43.26%. The major risk factors were patients ≥ 50 years old (OR = 2.19, 95% CI: 1.85–2.58; I2 = 97.44%), married (OR = 1.50, 95% CI: 1.35–1.68; I2 = 96.58%), with heterosexual contact as risk factor for infection (OR = 1.91, 95% CI: 1.73–2.11; I2 = 90.74%) and diagnosed in medical institutions (OR = 2.35,95% CI: 2.11–2.62; I2 = 96.05%). In middle or low HIV prevalence areas, patients ≥ 50 years old (P = 0.01), married (P < 0.01) and diagnosed in medical institutions (P = 0.01) were more likely to be presented late than in high prevalence areas. From 2016–2020, the OR of patients who were married and diagnosed in medical facilities were significantly lower than before (P < 0.01). Conclusion Patients ≥ 50 years old, married, with heterosexual contact as risk factor for infection, and diagnosed in medical institutions were risk factors of LP. Gender had no significant relationship with LP. In middle or low prevalence areas, patients who were ≥ 50 years old, married, and diagnosed in medical institutions were more likely to be presented late than in other areas. Married patients and those diagnosed in medical institutions after 2015 have a lower risk of LP than before.

Genetic network analysis of human immunodeficiency virus sexual transmission in rural Southwest China after the expansion of antiretroviral therapy: A population-based study

“…First, a GD of 0.0075 was chosen, which represents the evolution of HIV strains and transmission in 4–5 years. In China, the prevalence of late HIV diagnosis has reached 43% ( Sun et al, 2021 ). We do not have data on those newly infected patients with HIV, which may lead to a reduction in statistical power for the current analysis.…”

Missed opportunities for earlier diagnosis of HIV infection in people living with HIV in Thailand

“…The proportion of late presenters in Thailand was higher than in other countries in Asia and the Pacific [14]. Previous studies showed 43% of PLHIV in China [15] and 63% of those in Malaysia [16] had a late presentation. Older age, male gender, and persons who inject drugs were factors associated with a presentation into care at CD4 cell count <200 cells/mm 3 in Asian countries [17].…”

In-vivo pharmacokinetic studies of Dolutegravir loaded spray dried Chitosan nanoparticles as milk admixture for paediatrics infected with HIV

“…The infection with HIV directly or indirectly attacks the human immune system, which causes the depletion of the CD4 T-cells and helper T-cells 2 . According to World Health Organization (WHO) statistics in 2020, it was estimated that about 37.7 million are infected with HIV, that includes 1.8 million children (age < 15 years) 3 . The antiretroviral therapy to treat HIV patients covers five classes of anti-HIV drugs (entry inhibitor, fusion inhibitor, reverse transcriptase inhibitor, integrase inhibitor, protease inhibitor) 4 .…”